With one apparent cure under its belt, the biotech discussed in today’s article is now planning to leverage that success and take on a far… Read More »Now May Be The Perfect Time To Buy This Biotech “Leading The Race To Become The Future Of Medicine”
When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management… Read More »These 3 Struggling Biotechs Could Experience Spring Bumps
Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen… Read More »Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
After an initial analysis of clinical data back in May failed to demonstrate a statistically significant impact on the biomarkers associated with the disease, a… Read More »This Buy-Rated Biotech With An Effective Alzheimer’s Drug Has Upside Potential Of Over 100%
The company highlighted in today’s article – a direct-to-consumer telemedicine and wellness company – is the most bought OTC stock by insiders in the past… Read More »Revisiting The Most Bought OTC Stock By Insiders In The Past Month
What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s… Read More »What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
After a sharp decline during the March sell-off, shares of the sleep apnea technology company that’s the focus of today’s article have been marching higher.… Read More »Is There A Short Opportunity In This Sleep Apnea Stock?
The Reasons (Including One “Hidden Factor”) Why This Biopharmaceutical Stock Has Nearly Doubled Since Mid-March
Shares of the commercial-stage biopharmaceutical company highlighted in today’s article have nearly doubled since mid-March. The biggest reason why? The debut of the company’s hot… Read More »The Reasons (Including One “Hidden Factor”) Why This Biopharmaceutical Stock Has Nearly Doubled Since Mid-March
As has been the case with many small-cap biotech stocks amid the coronavirus pandemic, traders have gotten excited in recent weeks about the stock examined… Read More »Will The Coronavirus Be Different For This Perennial Disease Outbreak Loser?